Work

Safety and efficacy of GT719, an off-the-shelf CAR-NKT therapy, in adults with relapsed or refractory CD19-positive B-cell malignancies.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.7078

Authors: Yarong Liu, Jing Yu, Dehui Zou, Hongsheng Zhou, Liqing Ma, Bowen Li, Hang Chen, Derun Shen, Sisi Feng, Jingwei Sun, Pin Wang

Institutions: Grit Biotechnology (China), Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Ganzhou People's Hospital, University of Southern California

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162570499

Cites:

Cited by:

Related to: